2
|
Li P, Luo Y, Yu X, Mason E, Zeng Z, Wen J, Li W, Jalali MS. Readiness of healthcare providers for e-hospitals: a cross-sectional analysis in China before the COVID-19 period. BMJ Open 2022; 12:e054169. [PMID: 35190431 PMCID: PMC8861885 DOI: 10.1136/bmjopen-2021-054169] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
OBJECTIVES The growth and development of smartphones and eHealth technologies have enabled the potential for extended care hospitals (e-hospitals) in China in order to facilitate the success of a primary healthcare centre (PHC)-based integrated delivery model. Although the adoption of e-hospitals is essential, few studies have directed their research towards understanding the perspectives of healthcare providers. This study aims to identify the current readiness of healthcare providers to adopt e-hospital technologies, determine the factors influencing this adoption and describe the perceived facilitators and barriers in regard to working at e-hospitals. DESIGN A cross-sectional study conducted in Sichuan, China, between June and September 2019. SETTINGS Information was collected from healthcare providers who have more than 3 years of work experience from a tertiary hospital, secondary hospital, PHCs and private hospital. PARTICIPANTS 2298 medical professionals were included in this study. OUTCOME MEASURE This study included a self-administered questionnaire that was used to assess participants' sociodemographic characteristics, online medical practices, willingness to use e-hospitals and perceived facilitators/barriers to working at e-hospitals. Multivariate regression analysis was performed in order to evaluate the independent factors associated with e-hospital work. RESULTS Overall, 86.3% had a positive response towards working at e-hospitals. Age (p<0.05), familiarity with e-hospitals (p<0.001) and prior work practices in online healthcare settings (p<0.001) were associated with participants' readiness to work at e-hospitals. Gender, education level, professional level, the tier of their affiliated hospital and workload were not statistically associated. Healthcare providers who had positive attitudes towards e-hospitals considered improved efficiency, patient satisfaction, communication among physicians, increased reputation and income, and alleviated workload to be advantages of adoption. The participants who were unwilling to work at e-hospitals perceived lack of time, insufficient authenticity/reliability and underdeveloped policies as potential barriers. CONCLUSION Improving operative proficiency in electronic devices, accommodating to work schedules, increasing familiarity with e-hospitals and regulating practices will improve the readiness of healthcare providers to work at e-hospitals.
Collapse
Affiliation(s)
- Peiyi Li
- Department of Anesthesiology, Sichuan University West China Hospital, Chengdu, Sichuan, China
- Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology,West China Hospital, Sichuan University, Chengdu, Sichuan, China
- The Research Units of West China (2018RU012)-Chinese Academy of Medical Sciences, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Yunmei Luo
- West China Medical Publishers,West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Xuexin Yu
- Biomedical Big Data Center, Sichuan University West China Hospital, Chengdu, Sichuan, China
| | - Elizabeth Mason
- MGH Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts, USA
| | - Zhi Zeng
- Institute of Hospital Management, Sichuan University, West China Hospital, Chengdu, Sichuan, China
| | - Jin Wen
- Institute of Hospital Management, Sichuan University, West China Hospital, Chengdu, Sichuan, China
| | - Weimin Li
- Department of Respiratory and Critical Care Medicine, Sichuan University West China Hospital, Chengdu, China
- Institute of Respiratory Health, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China
- Precision Medicine Research Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China
| | - Mohammad S Jalali
- MGH Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts, USA
- Massachusetts Institute of Technology Sloan School of Management, Cambridge, Massachusetts, USA
| |
Collapse
|
4
|
McLachlan S, Dube K, Johnson O, Buchanan D, Potts HW, Gallagher T, Fenton N. A framework for analysing learning health systems: Are we removing the most impactful barriers? Learn Health Syst 2019; 3:e10189. [PMID: 31641685 PMCID: PMC6802533 DOI: 10.1002/lrh2.10189] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2018] [Revised: 02/01/2019] [Accepted: 03/05/2019] [Indexed: 01/18/2023] Open
Abstract
INTRODUCTION Learning health systems (LHS) are one of the major computing advances in health care. However, no prior research has systematically analysed barriers and facilitators for LHS. This paper presents an investigation into the barriers, benefits, and facilitating factors for LHS in order to create a basis for their successful implementation and adoption. METHODS First, the ITPOSMO-BBF framework was developed based on the established ITPOSMO (information, technology, processes, objectives, staffing, management, and other factors) framework, extending it for analysing barriers, benefits, and facilitators. Second, the new framework was applied to LHS. RESULTS We found that LHS shares similar barriers and facilitators with electronic health records (EHR); in particular, most facilitator effort in implementing EHR and LHS goes towards barriers categorised as human factors, even though they were seen to carry fewer benefits. Barriers whose resolution would bring significant benefits in safety, quality, and health outcomes remain.LHS envisage constant generation of new clinical knowledge and practice based on the central role of collections of EHR. Once LHS are constructed and operational, they trigger new data streams into the EHR. So LHS and EHR have a symbiotic relationship. The implementation and adoption of EHRs have proved and continues to prove challenging, and there are many lessons for LHS arising from these challenges. CONCLUSIONS Successful adoption of LHS should take account of the framework proposed in this paper, especially with respect to its focus on removing barriers that have the most impact.
Collapse
Affiliation(s)
- Scott McLachlan
- Electrical Engineering and Computer ScienceQueen Mary University of LondonLondonUK
| | - Kudakwashe Dube
- Fundamental SciencesMassey UniversityPalmerston NorthNew Zealand
| | | | - Derek Buchanan
- Fundamental SciencesMassey UniversityPalmerston NorthNew Zealand
| | - Henry W.W. Potts
- Institute of Health InformaticsUniversity College LondonLondonUK
| | | | - Norman Fenton
- Electrical Engineering and Computer ScienceQueen Mary University of LondonLondonUK
| |
Collapse
|
5
|
de Lusignan S, Hinton W, Konstantara E, Munro N, Whyte M, Mount J, Feher M. Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol). BMC Health Serv Res 2019; 19:284. [PMID: 31053136 PMCID: PMC6499968 DOI: 10.1186/s12913-019-4112-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2018] [Accepted: 04/22/2019] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND In the UK, type 2 diabetes mellitus (T2D) is largely managed in primary care. Delay in the intensification to injectable therapy, a form of clinical inertia, is associated with worse glycaemic control. UK general practice is highly computerised, with care being recorded on computerised medical record systems; this allows for quantitative analysis of clinical care but not of the underpinning decision-making process. The aim of this study is to investigate perceptions of patients and clinicians in primary care on the initiation of injectable therapies in T2D, and the context within which those decisions are made. METHODS This is a mixed methods study, taking a "realist evaluation" approach. The qualitative components comprise focus groups, interviews, and video recordings of simulated surgeries; the quantitative analysis: an overview of participating practices, elements of the video recording, and an online survey. We will recruit primary care clinicians (general practitioners and nurses) and patients from a representative sample of practices within the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) network. Participants will be patients with T2D, and primary care clinicians. Focus groups and semi-structured interviews will be recorded, transcribed verbatim and analysed using Framework Analysis. The simulated surgeries will include cases that might be escalated to injectable therapy. The consultation will be reviewed using the Calgary-Cambridge model to assess communication and determination of adherence to national prescribing guidelines. We will conduct multi-channel video recording including screen capture, clinician and patient facial expressions, wide angle view of the consultation, and the computerised medical record screen. This allows annotation and qualitative analysis of the video recordings, and statistical analyses for the quantitative data. We will also conduct an online survey of primary care clinicians' attitudes to, and perceptions of, initiation of injectable therapies, which will be analysed using summary statistics. DISCUSSION Results aim to provide a detailed insight into the dynamic two-way decision-making process underpinning use of injectable therapy for T2D. The study will provide insights into clinical practice and enable the development of training, interventions and guidelines that may facilitate, where appropriate, the intensification to injectable therapy.
Collapse
Affiliation(s)
- Simon de Lusignan
- Department of Clinical and Experimental Medicine, University of Surrey, The Leggett Building, Daphne Jackson Rd, Guildford, GU2 7XP, UK. .,Research and Surveillance Centre (RSC), Royal College of Practitioners (RCGP), 30 Euston Square, London, NW1 2FN, UK.
| | - William Hinton
- Department of Clinical and Experimental Medicine, University of Surrey, The Leggett Building, Daphne Jackson Rd, Guildford, GU2 7XP, UK
| | - Emmanouela Konstantara
- Department of Clinical and Experimental Medicine, University of Surrey, The Leggett Building, Daphne Jackson Rd, Guildford, GU2 7XP, UK
| | - Neil Munro
- Department of Clinical and Experimental Medicine, University of Surrey, The Leggett Building, Daphne Jackson Rd, Guildford, GU2 7XP, UK
| | - Martin Whyte
- Department of Clinical and Experimental Medicine, University of Surrey, The Leggett Building, Daphne Jackson Rd, Guildford, GU2 7XP, UK
| | - Julie Mount
- Real World Evidence, Eli Lilly and Company, Lilly House, Priestly Road, Basingstoke, Hampshire, RG24 9NL, UK
| | - Michael Feher
- Department of Clinical and Experimental Medicine, University of Surrey, The Leggett Building, Daphne Jackson Rd, Guildford, GU2 7XP, UK
| |
Collapse
|
6
|
Saillour-Glénisson F, Duhamel S, Fourneyron E, Huiart L, Joseph JP, Langlois E, Pincemail S, Ramel V, Renaud T, Roberts T, Sibé M, Thiessard F, Wittwer J, Salmi LR. Protocole of a controlled before-after evaluation of a national health information technology-based program to improve healthcare coordination and access to information. BMC Health Serv Res 2017; 17:297. [PMID: 28431579 PMCID: PMC5399879 DOI: 10.1186/s12913-017-2199-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2016] [Accepted: 03/30/2017] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Improvement of coordination of all health and social care actors in the patient pathways is an important issue in many countries. Health Information (HI) technology has been considered as a potentially effective answer to this issue. The French Health Ministry first funded the development of five TSN ("Territoire de Soins Numérique"/Digital health territories) projects, aiming at improving healthcare coordination and access to information for healthcare providers, patients and the population, and at improving healthcare professionals work organization. The French Health Ministry then launched a call for grant to fund one research project consisting in evaluating the TSN projects implementation and impact and in developing a model for HI technology evaluation. METHODS EvaTSN is mainly based on a controlled before-after study design. Data collection covers three periods: before TSN program implementation, during early TSN program implementation and at late TSN program implementation, in the five TSN projects' territories and in five comparison territories. Three populations will be considered: "TSN-targeted people" (healthcare system users and people having characteristics targeted by the TSN projects), "TSN patient users" (people included in TSN experimentations or using particular services) and "TSN professional users" (healthcare professionals involved in TSN projects). Several samples will be made in each population depending on the objective, axis and stage of the study. Four types of data sources are considered: 1) extractions from the French National Heath Insurance Database (SNIIRAM) and the French Autonomy Personalized Allowance database, 2) Ad hoc surveys collecting information on knowledge of TSN projects, TSN program use, ease of use, satisfaction and understanding, TSN pathway experience and appropriateness of hospital admissions, 3) qualitative analyses using semi-directive interviews and focus groups and document analyses and 4) extractions of TSN implementation indicators from TSN program database. DISCUSSION EvaTSN is a challenging French national project for the production of evidenced-based information on HI technologies impact and on the context and conditions of their effectiveness and efficiency. We will be able to support health care management in order to implement HI technologies. We will also be able to produce an evaluation toolkit for HI technology evaluation. TRIAL REGISTRATION ClinicalTrials.gov ID: NCT02837406 , 08/18/2016.
Collapse
Affiliation(s)
- Florence Saillour-Glénisson
- ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, University Bordeaux, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- CHU de Bordeaux, Pôle de Santé Publique, Service d’Information Médicale, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
| | - Sylvie Duhamel
- Département de Médecine Générale, Université de Bordeaux, 146, rue Léo Saignat 33076, Bordeaux, Cedex France
| | - Emmanuelle Fourneyron
- Institut de Santé Publique d’Epidémiologie et de Développement, Université de Bordeaux, 146, rue Léo Saignat 33076, Cedex F-33000 Bordeaux, France
| | - Laetitia Huiart
- CHU, Unité de Soutien Méthodologique, Saint-Denis, F-97400 France
- Groupe Hospitalier Est Réunion, Route Nationale 3 30, 97470, Saint-Benoît-de-Carmaux, France
| | - Jean Philippe Joseph
- Département de Médecine Générale, Université de Bordeaux, 146, rue Léo Saignat 33076, Bordeaux, Cedex France
| | - Emmanuel Langlois
- University Bordeaux/Sciences Po Bordeaux, Centre Emile Durkheim, F-33000 Bordeaux, France
- Centre Emile Durkheim, Science Politique et Sociologie Comparatives, Université de Bordeaux, 3Ter, Place de la Victoire 33076, Bordeaux, Cedex France
| | - Stephane Pincemail
- Institut de Santé Publique d’Epidémiologie et de Développement, Université de Bordeaux, 146, rue Léo Saignat 33076, Cedex F-33000 Bordeaux, France
| | - Viviane Ramel
- ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, University Bordeaux, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
| | - Thomas Renaud
- ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, University Bordeaux, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
| | - Tamara Roberts
- Département de Médecine Générale, Université de Bordeaux, 146, rue Léo Saignat 33076, Bordeaux, Cedex France
- University Bordeaux/Sciences Po Bordeaux, Centre Emile Durkheim, F-33000 Bordeaux, France
| | - Matthieu Sibé
- ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, University Bordeaux, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
| | - Frantz Thiessard
- ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, University Bordeaux, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
| | - Jerome Wittwer
- ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, University Bordeaux, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
| | - Louis Rachid Salmi
- ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, University Bordeaux, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- CHU de Bordeaux, Pôle de Santé Publique, Service d’Information Médicale, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
| | - for the EvaTSN Research group
- ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, University Bordeaux, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Research Center, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- CHU de Bordeaux, Pôle de Santé Publique, Service d’Information Médicale, 146 rue Léo Saignat, 33076, F-33000 Bordeaux, France
- Département de Médecine Générale, Université de Bordeaux, 146, rue Léo Saignat 33076, Bordeaux, Cedex France
- Institut de Santé Publique d’Epidémiologie et de Développement, Université de Bordeaux, 146, rue Léo Saignat 33076, Cedex F-33000 Bordeaux, France
- CHU, Unité de Soutien Méthodologique, Saint-Denis, F-97400 France
- University Bordeaux/Sciences Po Bordeaux, Centre Emile Durkheim, F-33000 Bordeaux, France
- Groupe Hospitalier Est Réunion, Route Nationale 3 30, 97470, Saint-Benoît-de-Carmaux, France
- Centre Emile Durkheim, Science Politique et Sociologie Comparatives, Université de Bordeaux, 3Ter, Place de la Victoire 33076, Bordeaux, Cedex France
| |
Collapse
|